Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395

Guoliang Sun; Hui Zhou; Ke Chen; Jin Zeng; Yangjun Zhang; Libin Yan; Weimin Yao; Junhui Hu; Tao Wang; Jinchun Xing; Kefeng Xiao; Lily Wu; Zhangqun Ye; Hua Xu

doi:10.1186/s13046-023-02613-4

Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395

J Exp Clin Cancer Res. 2023 Feb 8;42(1):43. doi: 10.1186/s13046-023-02613-4.

Authors

Guoliang Sun^#^{1

2}, Hui Zhou^#^{1

2}, Ke Chen^{1

2}, Jin Zeng^{1

2}, Yangjun Zhang^{1

2}, Libin Yan^{1

2}, Weimin Yao^{1

2}, Junhui Hu^{2

3}, Tao Wang⁴, Jinchun Xing⁴, Kefeng Xiao⁵, Lily Wu³, Zhangqun Ye^{1

2}, Hua Xu^{6

7}

Affiliations

¹ Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, P.R. China.
² Hubei Institute of Urology, Wuhan, 430030, P.R. China.
³ Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
⁴ Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, 361000, P.R. China.
⁵ Department of Urology, The People's Hospital of Shenzhen City, Shenzhen, 518000, P.R. China.
⁶ Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, P.R. China. xuhuawhu@163.com.
⁷ Hubei Institute of Urology, Wuhan, 430030, P.R. China. xuhuawhu@163.com.

^# Contributed equally.

No abstract available

Publication types

Retraction of Publication